--> VER +18%
RNS 05/01 07:01 [Delayed] Vernalis PLC VER FDA approves NDA for Tuzistra XR
BN 05/01 06:00 *VERNALIS VER FDA OKS NDA FOR TUZISTRA XR
BN 05/01 06:00 *VERNALIS VER FDA OKS NDA FOR TUZISTRA XR
Vernalis Says FDA Approves Tuzistra XR for Cough/Cold Treatment
2015-05-01 06:05:33.842 GMT
By Allison Connolly
(Bloomberg) -- Co. says Tuzistra XR is only U.S. codeine
based extended-release oral suspension cough-cold treatment.
* Co. aims to launch before 2015-2016 cough-cold season
* Webcast at 9:30am U.K. time
Link to Company News:{0886229D US <Equity> CN <GO>}
Link to Company News:{VER LN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
Allison Connolly at +44-20-3525-7043 or
aconnolly4@bloomberg.net
2015-05-01 06:05:33.842 GMT
By Allison Connolly
(Bloomberg) -- Co. says Tuzistra XR is only U.S. codeine
based extended-release oral suspension cough-cold treatment.
* Co. aims to launch before 2015-2016 cough-cold season
* Webcast at 9:30am U.K. time
Link to Company News:{0886229D US <Equity> CN <GO>}
Link to Company News:{VER LN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
Allison Connolly at +44-20-3525-7043 or
aconnolly4@bloomberg.net